Maxcyte Inc (MXCT)

Apr 28, 2026

MaxCyte (MXCT) price target decreased by 14.88% to 4.90 - MSN

Apr 28, 2026

Apr 27, 2026

MaxCyte announces 34% workforce reduction to cut costs - MSN

Apr 27, 2026

Apr 25, 2026

MaxCyte sees Q4 core revenue between $6.6M and $6.7M - MSN

Apr 25, 2026

Apr 24, 2026

MaxCyte, Inc. (MXCT) reports Q4 loss, misses revenue estimates - MSN

Apr 24, 2026

Apr 23, 2026

MXCT (MaxCyte Inc.) shares fall 4.09 percent despite Q4 2025 EPS beat and double-digit year over year revenue decline.Investment Signal Network - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 22, 2026

MXCT (MaxCyte Inc.) shares climb more than four percent after Q4 2025 EPS tops consensus analyst expectations.Risk Report - Cổng thông tin điện tử Tỉnh Sơn La

Apr 22, 2026

Apr 21, 2026

MaxCyte, Inc. (NASDAQ:MXCT) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Apr 21, 2026

Apr 18, 2026

Form S-8Securities to be offered to employees in employee benefit plans - ADVFN

Apr 18, 2026

Apr 18, 2026

Wall Street Zen Downgrades MaxCyte (NASDAQ:MXCT) to Sell - MarketBeat

Apr 18, 2026

Apr 17, 2026

MaxCyte (MXCT) CFO receives 187,500 restricted stock units in equity grant - Stock Titan

Apr 17, 2026

Apr 16, 2026

MaxCyte (MXCT) price target decreased by 11.67% to 4.33 - MSN

Apr 16, 2026

Apr 16, 2026

Earnings Call Summary | MaxCyte(MXCT.US) Q4 2025 Earnings Conference - 富途牛牛

Apr 16, 2026

Apr 11, 2026

FOMO Trade: Is MaxCyte Inc stock risky to hold nowWeekly Profit Recap & Low Volatility Stock Recommendations - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Rally Mode: Can MaxCyte Inc sustain its profitability2026 Breakouts & Growth Focused Stock Reports - baoquankhu1.vn

Apr 11, 2026

Apr 11, 2026

Fed Watch: Will MaxCyte Inc benefit from rising consumer demand2026 Rallies & Weekly Sector Rotation Insights - baoquankhu1.vn

Apr 11, 2026

Apr 10, 2026

MaxCyte (MXCT) CFO awarded 375,000 employee stock options at $0.6762 - Stock Titan

Apr 10, 2026

Apr 10, 2026

MAXCYTE (MXCT) CFO Parmeet Ahuja named reporting insider in Form 3 - Stock Titan

Apr 10, 2026

Apr 10, 2026

Mirabella exit leaves MaxCyte (NASDAQ: MXCT) ownership at 0% after Jan 5, 2026 - Stock Titan

Apr 10, 2026

Apr 10, 2026

Activity Recap: Is MaxCyte Inc showing insider buying2026 WrapUp & Technical Confirmation Trade Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Aug Final Week: Is MaxCyte Inc being accumulated by smart money - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Aug Rallies: Is MaxCyte Inc a momentum stock2026 Intraday Action & Technical Pattern Alert System - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Pullback Watch: Is MaxCyte Inc forming a breakout patternWall Street Watch & Fast Exit and Entry Strategy Plans - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

MaxCyte, Inc. (NASDAQ:MXCT) Q4 2025 earnings call transcript - MSN

Apr 08, 2026

Apr 07, 2026

Quarterly Earnings: Is MaxCyte Inc stock a value trap2026 Key Highlights & Growth Focused Entry Reports - baoquankhu1.vn

Apr 07, 2026

Apr 06, 2026

Is MaxCyte (MXCT) Stock Good for Passive Investors | Price at $0.74, Down 1.31%Early Entry - UBND thành phố Hải Phòng

Apr 06, 2026

Apr 04, 2026

MXCT PE Ratio & Valuation, Is MXCT Overvalued - Intellectia AI

Apr 04, 2026

Apr 04, 2026

MXCT Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 04, 2026

Apr 03, 2026

MXCT Stock Analysis: MaxCyte Inc. Biotech Play Holds 0.75 Support Post Minor Daily Gain - Cổng thông tin điện tử Tỉnh Sơn La

Apr 03, 2026

Apr 02, 2026

Big Money Moves: Is MaxCyte Inc stock risky to hold now2026 News Drivers & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn

Apr 02, 2026

Apr 01, 2026

MXCT Stock Analysis: MaxCyte Inc. biotech holds 0.71 dollar mark with mild daily gain - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 01, 2026

Mar 31, 2026

MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Mar 31, 2026

Mar 31, 2026

MaxCyte (MXCT) CEO awarded 600,000 options and 300,000 RSUs - Stock Titan

Mar 31, 2026

Mar 31, 2026

New MaxCyte CFO gets 562,500-share inducement award under Nasdaq rule - Stock Titan

Mar 31, 2026

Mar 31, 2026

RSI Check: Is now the right time to enter MaxCyte IncTrade Entry Report & Long-Term Growth Portfolio Plans - baoquankhu1.vn

Mar 31, 2026

Mar 31, 2026

MaxCyte (NASDAQ:MXCT) Upgraded by Wall Street Zen to Hold Rating - MarketBeat

Mar 31, 2026

Mar 29, 2026

Risk On: Will MaxCyte Inc outperform small cap indexes2026 Review & Risk Managed Investment Entry Signals - baoquankhu1.vn

Mar 29, 2026

Mar 28, 2026

MaxCyte Appoints Parmeet Ahuja as New Chief Financial Officer to Drive Strategic Growth - Minichart

Mar 28, 2026

Mar 27, 2026

MaxCyte outlines $30M–$32M 2026 revenue target as ExPERT DTx launch and SPL milestones drive outlook - MSN

Mar 27, 2026

Mar 27, 2026

MaxCyte Earnings Call Weighs Short‑Term Pain, Long‑Term Upside - The Globe and Mail

Mar 27, 2026

Mar 27, 2026

MaxCyte Appoints New Chief Financial Officer Ahuja - TipRanks

Mar 27, 2026

Mar 27, 2026

MaxCyte appoints Parmeet Ahuja as CFO, succeeding Douglas Swirsky - TradingView

Mar 27, 2026

Mar 27, 2026

New MaxCyte (NASDAQ: MXCT) CFO Parmeet Ahuja joins from Agilent - Stock Titan

Mar 27, 2026